Small cell lung cancer: Clinical practice guidelines in oncology Review uri icon

Overview

MeSH Major

  • Brain Neoplasms
  • Lung Neoplasms
  • Small Cell Lung Carcinoma

abstract

  • Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.

publication date

  • January 2013

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC3715060

PubMed ID

  • 23307984

Additional Document Info

start page

  • 78

end page

  • 98

volume

  • 11

number

  • 1